Effect of streptococcal preparation (picibanil) on the postoperative rise in serum alanine aminotransferase activity in patients with urogenital cancer.
The effect of Picibanil, a streptococcal agent, on the development of liver injury after operations for urogenital cancer was studied retrospectively in the light of serum alanine aminotransferase (ALT) activity. The series comprised 32 cases receiving Picibanil and 33 controls with otherwise comparable clinical backgrounds. Picibanil reduced the incidence of postoperative ALT rise over 50 U/l within 6 weeks but increased it thereafter. The increase in ALT activity after 6 weeks was relatively small and was seen more often in patients given blood transfusions. It was interpreted as retardation and suppression of ALT rise and as being related to the induction of interferon or to immunopotentiation. Other antihepatotoxic effects of Picibanil, due to its antioxidant activity, for example, may also account for the prevention of the early postoperative rise in ALT activity.
D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood*; D001688:Biological Products / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008107:Liver Diseases / Q000517:prevention & control; D008297:Male; D008875:Middle Aged; D010844:Picibanil / Q000627:therapeutic use*; D011184:Postoperative Period; D014565:Urogenital Neoplasms / Q000201:enzymology* / Q000601:surgery
D001688:Biological Products; D010844:Picibanil; D000410:Alanine Transaminase